
Penumbra PEN
$ 332.71
0.21%
Annual report 2025
added 02-25-2026
Country |
|
IPO year |
2015 |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
38.9 M |
Market Cap[1] |
$ 12.9 B |
EBITDA (LTM) |
$ 171 M |
P/E (LTM) |
80.62 |
P/S (LTM) |
9.8 |
EPS (LTM) |
4.12 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 186.99 | 1.25 % | $ 14 B | Nasdaq Global Select Market,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.65 | -0.98 % | $ 1.71 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 297.14 | 1.6 % | $ 8.38 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.54 | 5.04 % | $ 133 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 39.58 | -0.8 % | $ 5.9 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 64.53 | 1.13 % | $ 95.5 B | NYSE,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.6 | 1.32 % | $ 37.3 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 1.96 | -1.01 % | $ 1.19 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 10.45 | 0.67 % | $ 296 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Inogen
INGN
|
$ 6.3 | -0.71 % | $ 168 M | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.75 | 1.78 % | $ 218 M | NYSE American | ||
|
IRIDEX Corporation
IRIX
|
$ 1.02 | -0.49 % | $ 17.3 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 6.19 | 2.48 % | $ 74 M | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 94.86 | -0.07 % | $ 12.8 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.9 | 0.22 % | $ 420 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 4.84 | 9.38 % | $ 1.02 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Myomo
MYO
|
$ 0.79 | 1.42 % | $ 33.1 M | NYSE American | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 10.96 | 0.74 % | $ 393 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 56.77 | -0.16 % | $ 1.67 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.24 | -1.26 % | $ 1.22 B | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 65.08 | 0.14 % | $ 3.55 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 87.37 | -1.4 % | $ 3.03 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.76 | - | $ 123 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 78.15 | -0.06 % | $ 45.7 B | NYSE,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.